已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women

德诺苏马布 医学 骨矿物 绝经后妇女 骨质疏松症 骨小梁评分 腰椎 腰椎 内科学 泌尿科 腰椎 外科 定量计算机断层扫描
作者
Namki Hong,Sungjae Shin,Hyun-Jae Kim,Sung‐Joon Cho,Jinah Park,Yumie Rhee
出处
期刊:Journal of Bone and Mineral Research [Wiley]
标识
DOI:10.1093/jbmr/zjae179
摘要

Romosozumab following anti-resorptive can be an effective sequential treatment strategy to improve bone strength. However, whether the transition to romosozumab after denosumab is associated with greater improvement in bone mineral density (BMD) and trabecular bone score (TBS) compared to denosumab continuation remains unclear. In this propensity score-matched cohort study, we analyzed data from postmenopausal women who initiated denosumab between 2017 and 2020. Individuals who were transited to 12 months of romosozumab after denosumab were 1:1 matched to those who continued an additional 12 months of denosumab (n = 86 for each group; denosumab-romosozumab [DR] and denosumab-denosumab [DD]). Mean BMD gain by denosumab treatment in matched DR and DD groups from denosumab initiation to transition (median 4 times [range 2 to 8]) was +4.8% and + 2.0% in the lumbar spine and total hip. DR group showed greater LS BMD gain compared to the DD group (+6.8 vs. +3.3% point, P<.001) for 12 months post-transition independent of the duration of prior denosumab treatment, yielding greater overall LS BMD gain in DR compared to DD (+11.6% vs. +8.0%, P<.001). DD group showed continued improvement of hip BMD, whereas hip BMD was maintained but not improved in the DR group. DR group was associated with greater TBS improvement than the DD group (2.9% vs 1.0%, P=.042). One month after the transition to romosozumab from denosumab, P1NP immediately increased above the level of denosumab initiation with relatively suppressed CTx, creating a transient anabolic window. For 12 months follow-up, one incident morphometric vertebral fracture and one patella fracture were observed in DD, whereas one ankle fracture was observed in the DR group. Romosozumab following denosumab improved lumbar spine BMD and TBS greater than denosumab continuation in postmenopausal women.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8秒前
8秒前
FashionBoy应助Guoqiang采纳,获得10
9秒前
黄橙子完成签到 ,获得积分10
14秒前
辛勤晓旋完成签到,获得积分10
15秒前
18秒前
AU完成签到 ,获得积分10
20秒前
HS完成签到,获得积分10
24秒前
欣慰问凝完成签到 ,获得积分10
24秒前
leave完成签到,获得积分10
24秒前
Guoqiang发布了新的文献求助10
24秒前
HDD完成签到,获得积分10
25秒前
18367215156完成签到,获得积分10
25秒前
一定能发布了新的文献求助10
26秒前
欣6完成签到 ,获得积分10
28秒前
番茄炒蛋完成签到 ,获得积分10
44秒前
搜集达人应助Guoqiang采纳,获得10
45秒前
斯文败类应助Guoqiang采纳,获得10
45秒前
科研通AI2S应助Guoqiang采纳,获得10
45秒前
小墨应助Guoqiang采纳,获得10
45秒前
科研通AI2S应助Guoqiang采纳,获得10
45秒前
欣5完成签到 ,获得积分10
45秒前
Orange应助活力的采枫采纳,获得10
46秒前
a成完成签到 ,获得积分10
49秒前
52秒前
郭梓韵发布了新的文献求助10
55秒前
1分钟前
香蕉觅云应助科研通管家采纳,获得10
1分钟前
上官若男应助科研通管家采纳,获得10
1分钟前
田様应助科研通管家采纳,获得10
1分钟前
英姑应助科研通管家采纳,获得10
1分钟前
SciGPT应助科研通管家采纳,获得10
1分钟前
Frank应助科研通管家采纳,获得30
1分钟前
大个应助科研通管家采纳,获得10
1分钟前
郭梓韵完成签到,获得积分10
1分钟前
1分钟前
温暖南莲完成签到,获得积分10
1分钟前
1分钟前
鲤鱼安青完成签到 ,获得积分10
1分钟前
chenyuns发布了新的文献求助20
1分钟前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
《粉体与多孔固体材料的吸附原理、方法及应用》(需要中文翻译版,化学工业出版社,陈建,周力,王奋英等译) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3085205
求助须知:如何正确求助?哪些是违规求助? 2738111
关于积分的说明 7548402
捐赠科研通 2387728
什么是DOI,文献DOI怎么找? 1266084
科研通“疑难数据库(出版商)”最低求助积分说明 613281
版权声明 598492